Ocular toxicity of mitomycin-C

International Ophthalmology Clinics

Volumn 39, Issue 2, 1999, Pages 79-90

  Hardten, David R ^a   Samuelson, Thomas W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

CONJUNCTIVA TUMOR; EYE TOXICITY; EYE TUMOR; FIBROSIS; FILTERING OPERATION; GLAUCOMA; HUMAN; LUNG CARCINOMA; MELANOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; PTERYGIUM; REVIEW; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; TRABECULECTOMY; UTERINE CERVIX CARCINOMA;

ANTIBIOTICS, ANTINEOPLASTIC; CONJUNCTIVAL NEOPLASMS; EYE; EYE DISEASES; FILTERING SURGERY; GLAUCOMA; HUMANS; MITOMYCIN; PTERYGIUM;

EID: 0032900484     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199903920-00007     Document Type: Review

References (49)

1. Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics, ed 8. New York: Pergamon Press, 1990;1247-1248
2. Bowman WC, Rand MJ, eds. Textbook of pharmacology, vol 3, ed 2. Oxford: Blackwell, 1980:14
3. Frucht-Pery J, Ilsar M. The use of low-dose mitomycin-C for prevention of recurrent pterygium. Ophthalmology 1994;101:759-762
4. Hayasaka S, Noda S, Yamamoto Y, Setogawa T. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol 1988;106:715-718
5. Hayasaka S, Noda S, Yamamoto Y, Setogawa T. Postoperative instillation of mitomycin C in the treatment of recurrent pterygium. Ophthalmic Surg 1989;20:580-583
6. Kunitomo N, Mori S. Studies on the pterygium: IV. A treatment of the pterygium by mitomycin c instillation. Nippon Ganka Gakkai Zasshi 1963;67:601-607
7. Mori S, Murakami N, Kunitomo N. Postoperative treatment of pterygium with mitomycin C. A clinical follow-up. Jpn J Ophthalmol 1968;12(1):30-36
8. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988;95:813-821
9. Singh G, Wilson MR, Foster CS. Long-term follow-up study of mitomycin eye drops as adjunctive treatment for pterygia and its comparison with conjunctival autograft transplantation. Cornea 1990;9:331-334
10. Cardillo JA, Alves MR, Ambrosio LE, et al. Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology 1995; 102:1949-1952
11. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 1996;15(5): 537-540
12. Frucht-Pery J, Ilsar M, Hemo I. Single dosage of mitomycin c for prevention of recurrent pterygium: preliminary report. Cornea 1994;13:411-413
13. Lam DSC, Wong AKK, Fan DSP, et al. Intraoperative mitomycin C to prevent recurrence of pterygium after excision. A 30-month follow-up study. Ophthalmology 1998;105:901-905
14. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin-c in refractory glaucoma. J Ocul Pharmacol 1990;6(3): 175-182
15. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991;98(3):317-321
16. Pasquale LR, Thibault D, Dorman-Pease ME, et al. Effect of topical mitomycin-c on glaucoma filtration surgery in monkeys. Ophthalmology 1992;99(1):14-18
17. Skuta GL, Beeson CC, Higginbotham EJ. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1992;99: 438-444
18. Wilson MR, Lee DA, Baker RS, et al. The effects of topical mitomycin on glaucoma filtration surgery in rabbits. J Ocul Pharmacol 1991;7:1-8
19. Yamamoto T, Varani J, Soong HK, Lichter PR. Effects of 5-fluorouracil and mitomycin-c on cultured rabbit subconjunctival fibroblasts. Ophthalmology 1990;97(9):1204-1210
20. Barrada A, Peyman GA, Greenberg D, et al. Toxicity of antineoplastic drugs in vitrectomy infusion fluids. Ophthalmic Surg 1983;14(10):845-847
21. Peyman GA, Greenberg D, Fishman GA, et al. Evaluation of toxicity of intravitreal antineoplastic drugs. Ophthalmic Surg 1984;15(5):411-413
22. Lewallen S. A randomized trial of conjunctival autografting for pterygium in the tropics. Ophthalmology 1989;96:1612-1614
23. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985;92:1461-1470
24. Dunn JP, Seamone CD, Ostler HB, et al. Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy [letter]. Am J Ophthalmol 1991;112:343-344
25. Ewing-Chow DA, Romanchuk KG, Gilmour GR, et al. Corneal melting after pterygium removal followed by topical mitomycin C therapy. Can J Ophthalmol 1992;27:197-199
26. Fujitani A, Hayasaka S, Shibuya Y, Noda S. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica 1993;207:162-164
27. Fukamachi Y, Hitika N. Ocular complication following pterygium operation and instillation of mitomycin C. Nippon Ganka Kiyo 1981;32:197
28. Gupta S, Basti S. Corneoscleral, ciliary body, and vitreoretinal toxicity after excessive instillation of mitomycin C [letter]. Am J Ophthalmol 1992;114:503-504
29. Penna EP. Mitomycin-c after pterygium excision [letter]. Ophthalmology 1993;100:976
30. Rubinfeld RS. Mitomycin-C after pterygium surgery [reply]. Ophthalmology 1993; 100:977-978
31. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99:1647-1654
32. Singh G. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium [letter]. Am J Ophthalmol 1989;107:570-571
33. Singh G. Mitomycin-C after pterygium excision [letter]. Ophthalmology 1993; 100:976-977
34. Sugar A. Mitomycin-C after pterygium excision [reply]. Ophthalmology 1993;100:977
35. Yamanouchi U. A case of scleral calcification due to mitomycin C instillation after pterygium operation. Nippon Ganka Kiyo 1978;29:1221
36. Yamanouchi U, Mishim K. Eye lesions due to mitomycin C installation after pterygium operation. Nippon Ganka Kiyo 1967;18:854-861
37. Yamanouchi U, Takaku I, Tsuda N, et al. Scleromalacia presumably due to mitomycin C installation after pterygium excision. Jpn J Clin Ophthalmol 1979;33:139-144
38. MacKenzie FD, Hirst LW, Kynaston B, Bain C. Recurrence rate and complications after beta irradiation for pterygium. Ophthalmology 1991;98:1776-1781
39. Tarr KH, Constable IJ. Late complications of pterygium treatment. Br J Ophthalmol 1980;64:496-505
40. The Fluorouracil Filtering Surgery Study Group. Fluorouracil filtering surgery study group one-year follow-up. Am J Ophthalmol 1989;108:625-635
41. Heuer DK, Parrish RK II, Gressel MG, et al. 5-Fluorouracil and glaucoma filtering surgery: II. A pilot study. Ophthalmology 1984;91:384-394
42. Samuelson TW. 5-Fluorouracil induced corneal toxicity. Association for Research in Vision and Ophthalmology (ARVO) glaucoma paper presentations, Sarasota, FL, May 1992
43. Cheung JC, Wright MM, Murali S, Pederson JE. Intermediate-term outcome of variable dose mitomycin-c filtering surgery. Ophthalmology 1997;04(1):143-149
44. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin-c. Trans Asia-Pacific Acad Ophthalmol 1983; 9: 172-177
45. Greenfield DS, Liebmann JM, Jee J, Ritch R. Late onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol 1998;116:443-447
46. Greenfield DS, Suner IJ, Miller MP, et al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996;114:943-949
47. Suner IJ, Greenfield DS, Miller MP, Palmberg PF. Hypotony maculopathy following filtering surgery with mitomycin-c incidence and treatment. Ophthalmology 1997; 104: 207-215
48. Ciulla TA, Beck AD, Topping TM Baker AS. Blebitis, early endophthalmitis, and late endophthalmitis after glaucoma filtering surgery. Ophthalmology 1997;104:986-995
49. Finger PT, Czechonska G, Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol 1998;82:476-479